Part,  Chapter, Paragraph

 1   II,     5.  5.Int|           mental ill-health in their lifetime, costing the EU27 countries
 2   II,     5.  5.Int|             burden of disease.~ ~The lifetime incidence of severe mental
 3   II,     5.  5.  1|         depression are quite common. Lifetime prevalence of major depression
 4   II,     5.  5.  1|           six EU Member States found lifetime prevalence of having any
 5   II,     5.  5.  1|         between 10-22% and projected lifetime prevalence 13-26% in the
 6   II,     5.  5.  1|            Netherlands, and Spain.~ ~Lifetime prevalence of any mood disorder
 7   II,     5.  5.  1|             in the ESEMeD countries. Lifetime prevalence of any anxiety
 8   II,     5.  5.  1|               Table 5.5.1.1 presents lifetime and 12 month prevalence
 9   II,     5.  5.  1|           countries.~ ~Table 5.5.1.1 Lifetime and 12 month prevalence
10   II,     5.  5.  1|           had had suicidal thoughts. Lifetime suicide attempts were higher
11   II,     5.  5.  1|           disorder.~ ~Table 5.5.1.3. Lifetime suicidal behaviour in some
12   II,     5.  5.  1|              2):89-94.~ ~K B (2007): Lifetime prevalence and age-of-onset
13   II,     5.  5.  1| Investigators (2007). Differences in lifetime use of services for mental
14   II,     5.  5.  3|             prevalence 3.3 per 1000, lifetime prevalence 4.0 per 1000
15   II,     5.  5.  3|          prevalence 4.0 per 1000 and lifetime morbid risk 7.2 per 1000,
16   II,     5.  5.  3|    calculated estimates based on the lifetime prevalence rate, the service
17   II,     5.  5.  3|           schizophrenia during their lifetime is about seven per 1 000
18   II,     5.  5.  3|           period prevalence, 4.0 for lifetime prevalence and 7.2 for lifetime
19   II,     5.  5.  3|      lifetime prevalence and 7.2 for lifetime morbidity risk (Saha et
20   II,     5.  5.  3|            where the value noted for lifetime prevalence is 0.5 to 1.0%.~
21   II,     5.  5.  3|          cause of deaths assignment.~Lifetime suicide rates for schizophrenia
22   II,     5.  5.  3|               published estimates of lifetime suicide prevalence in schizophrenia
23   II,     5.  5.  3|          commit suicide during their lifetime, usually near illness onset” (
24   II,     5.  5.  3|  Jones-Edwards G, Roberts AP (2006): Lifetime suicide rates in treated
25   II,     5.  5.  3|              Bostwick JM (2005): The lifetime risk of suicide in schizophrenia:
26   II,     5.  5.  3|             value of future years of lifetime lost due to premature mortality (
27   II,     5.  5.  3|              life lost, YLLs) and of lifetime adjusted for the disease
28   II,     5.  6.  3|              from the condition. The lifetime risk or the 10 year probability
29   II,     5.  6.  3|           van Staa et al, 2001). The lifetime risk of fragility fractures
30   II,     5.  6.  3|               Table 5.6.7. Estimated lifetime risks of fractures in the
31   II,     5.  6.  3|           the working population and lifetime recurrences of up to 85% (
32   II,     5.  6.  3|            back pain.~ ~Prevalence~ ~Lifetime prevalence varies between
33   II,     5.  9.  4|         Italian centres, showed that lifetime asthma and current wheeze
34   II,     5.  9.  4|              children born in Italy (lifetime asthma: 5.4% and 9.7% respectively,
35   II,     5.  9.  4|               0.04). Lower risks for lifetime asthma (prevalence odds
36   II,     5. 11.  3|              by skin problems during lifetime. The prevalence of skin
37   II,     5. 11.  3|            school children (5-6 yrs)~Lifetime prevalence=20.7%~Broberg
38   II,     5. 11.  3|              school children (9 yrs)~Lifetime prevalence=15.2% Point prevalence=
39   II,     5. 11.  3|          school children (12-16 yrs)~Lifetime prevalence=21.3% 1-year
40   II,     5. 11.  3|        strongly linked to cumulative lifetime sun exposure (Rosso et al,
41   II,     5. 14.  1|             disease throughout their lifetime (Selwitz and Ismail, 2007).
42   II,     5. 14.  3|             of dental caries lasts a lifetime because once the tooth structure
43   II,     9.  2.  1|            greatly enhanced risk for lifetime healthcare problems such
44   II,     9.  3.  1|            are affected. The overall lifetime risk for fractures in women
45   II,     9.  3.  3|            of sexual partners during lifetime has decreased from 1993
46   II,     9.  3.  3|           reported that during their lifetime they had experienced homosexual
47   II,     9.  3.  3|            intercourses during their lifetime (Weiss,2008).~ ~Similar
48   II,     9.  3.  3|      partners (during the last year, lifetime);~· condom use at most recent
49   II,     9.  4.  1|              budget throughout their lifetime (and not as a burden).~ ~
50   II,     9.  5.  1|         population increases through lifetime, women are at a higher risk
51   II,     9.  5.  3|       partner or ex-partner in their lifetimeApproximately 2 women
52   II,     9.  5.  3|             consultations over their lifetime than the non-victimised.
53   II,     9.  5.  3|             per cent of women report lifetime experience of alcohol misuse
54  III,    10.  2.  1|              alcohol consumed over a lifetime alcohol intake increases
55  III,    10.  2.  1|              alcohol consumed over a lifetime and a decreased volume of
56  III,    10.  2.  1|            it at least once in their lifetime are not current users anymore.
57  III,    10.  2.  1|               Among 15-16 year olds, lifetime (i.e. at least once in their
58  III,    10.  2.  1|             olds. In most countries, lifetime prevalence of cocaine use
59  III,    10.  2.  1|          cocaine use is 2% or lower. Lifetime ecstasy use was reported
60  III,    10.  2.  1|             3.1). An increase in the lifetime prevalence of the use of
61  III,    10.  2.  1|       occurred.~ ~Figure 10.2.1.3.1. Lifetime prevalence of cannabis among
62  III,    10.  2.  1|            among 15-34 year olds and lifetime prevalence might grow dramatically
63  III,    10.  2.  1|              adults in Europe report lifetime use of cannabis, 13% (3-
64  III,    10.  2.  1|           figure is 5.3% for average lifetime use, with six countries
65  III,    10.  2.  1|          figures are 5.1% and 5% for lifetime use and 1.5% and 2% for
66  III,    10.  2.  1|            and 2% for last year use. Lifetime prevalence of LSD use ranges
67  III,    10.  2.  1|         health issue considering the lifetime impact of lack of care in
68  III,    10.  3.  1|       significant part of a person’s lifetime UVR exposure occurs before
69   IV,    11.  6.  3|            periods of poverty over a lifetime. While most redistribution
70   IV,    11.  6.  3|          show a redistribution from ‘lifetime richest’ to ‘lifetime poorest’,
71   IV,    11.  6.  3|          from ‘lifetime richest’ to ‘lifetime poorest’, although the redistribution